Cart
sales@molnova.com
Acriflavine Hydrochloride
CAS No. 8063-24-9
Acriflavine Hydrochloride( Acriflavine HCl )
Catalog No. M27171 CAS No. 8063-24-9
Acriflavine Hydrochloride is a HIF-1α inhibitor. It acts by targeting HIF-1α-mediated pathways and decreasing the level of PGK1, VEGF, and HIF-1α in vitro and in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAcriflavine Hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcriflavine Hydrochloride is a HIF-1α inhibitor. It acts by targeting HIF-1α-mediated pathways and decreasing the level of PGK1, VEGF, and HIF-1α in vitro and in vivo.
-
DescriptionAcriflavine Hydrochloride is a HIF-1α inhibitor. It acts by targeting HIF-1α-mediated pathways and decreasing the level of PGK1, VEGF, and HIF-1α in vitro and in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsAcriflavine HCl
-
PathwayAngiogenesis
-
TargetHIF/HIF Prolyl-hydroxylase
-
RecptorAntifungal
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number8063-24-9
-
Formula Weight259.74
-
Molecular FormulaC14H14ClN3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[Cl-].C[n+]1c2cc(N)ccc2cc2ccc(N)cc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gurram RK, et al. Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs). J Biol Chem. 2014 Jun 20;289(25):17515-28.
molnova catalog
related products
-
Izilendustat
Tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-carboxylate inhibit of human recombinant EGLN-1 as substrate after 20 mins by mass spectrophotometric analysis.
-
THS-044
THS-044 is a low micromolar HIF2α PAS-B binding compound (Kd=2 uM).
-
TAT-cyclo-CLLFVY
Selective HIF-1 dimerization inhibitor. Blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β (IC50 = 1.3 μM). Inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cancer cells in vitro. Also reduces tubularization of hypoxic HUVECs.
